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Abstract C-terminal domain tissue inhibitor of metalloprotein-
ases-3 (TIMP-3) mutations cause the rare hereditary blindness
Sorsby’s fundus dystrophy (SFD), which involves loss of retinal
pigment epithelial (RPE) cells. Since wild-type TIMP-3 causes
apoptosis, we investigated whether SFD TIMP-3 might kill
RPE and other cells. Plasmid-mediated overexpresion of Ser-
156, Gly-167, Tyr-168 and Ser-181 SFD mutant TIMP-3 de-
creased RPE viability to 221 8, 201 6, 321 5, 301 12% (SFD
mutants all P6 0.01 versus wild-type 501 8%) and similarly
increased propidium iodide staining and in situ end labelling.
Adenovirus-mediated overexpression of the Gly-167 mutant
also caused RPE apoptosis dose-dependently. Apoptosis of
RPE cells might therefore contribute to the pathology of SFD.
4 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The four tissue inhibitors of metalloproteinases (TIMPs)
have a common structure with three N-terminal and three
C-terminal disulphide bonded loops that divide the protein
into two domains [1]. TIMPs share the ability to inhibit
most members of the matrix degrading metalloproteinase
(MMP) family (MMPs), which mediate matrix turnover dur-
ing physiological and pathological tissue remodelling [1]. Pro-
apoptotic e¡ects have been identi¢ed for TIMP-3 [2,3] and,
more recently, TIMP-4 [4]. The basis of apoptosis induced by
TIMP-3 has yet to be fully de¢ned, although it is a property
of the N-terminal domain and requires the critical N-terminal
cysteine residue necessary for inhibition of MMPs [5].
Sorsby’s fundus dystrophy (SFD) is a rare autosomal dom-
inant retinal degeneration which becomes apparent in the
fourth decade of life [6]. An early sign is the deposition of
lipids and protein in the Bruch’s membrane, which separates
the retinal pigment epithelium (RPE) from its blood supply,
the choriocapillaris [7]. These abnormal deposits thicken the
Bruch’s membrane and may impede the transport of essential
metabolites from the choriocapillaris to the RPE, thus causing
RPE dysfunction and cell loss [8]. In addition or consequen-
tially, neovessels invade through the Bruch’s membrane and
the ensuing sub-retinal haemorrhaging leads to macular scar-
ring and irreversible loss of central vision [9]. In this respect,
SFD is similar to age-related macular degeneration (ARMD),
which ranks as the most common cause of blindness in devel-
oped countries.
Patients with SFD have mutations in exon 5 of the TIMP-3
gene [10^14]. SFD mutant TIMP-3 proteins have gained or
lost a cysteine residue in their C-terminal region, thus gener-
ating a free SH group. TIMP-3 is synthesised by RPE cells
and accumulates in the Bruch’s membrane [15^22]. Since SFD
mutant TIMP-3 proteins contain an intact N-terminal domain
we hypothesised that they might possess the ability to cause
apoptosis of RPE cells.
2. Materials and methods
2.1. Reagents and cells
All chemicals, unless otherwise stated, were obtained from Sigma
Chemical. Culture media (MEM, DMEM and OptiMEM), foetal calf
serum (FCS), glutamine, a penicillin/streptomycin antibiotic mix and
Lipofectamine1 were obtained from Gibco BRL. Anti-cytokeratin 18
and anti-pancytokeratin £uorescein-conjugated monoclonal antibod-
ies were obtained from Sigma Chem. Anti-TIMP-3 polyclonal anti-
body, raised against loop I of TIMP-3 in rabbit, was obtained from
Chemicon. Plasmids containing the cDNAs of wild-type and SFD
mutant TIMP-3 under a metallothein promoter were generously do-
nated by Professors D. Edwards and G. Murphy (University of Nor-
wich, UK). These were cleaved with the SmaI enzyme and subcloned
into pCI.neo vectors under a cytomegalovirus early immediate pro-
moter to enhance expression of the TIMP-3 proteins in our trans-
fection system. Additional plasmids for transfections were prepared
with plasmid mini kits (Quiagen). Alternatively, wild-type and mutant
(Gly-167) TIMP-3 were subcloned into adenovirus shuttle vector
pal200 (a generous gift from G. Wilkinson, University of Wales, Col-
lege of Medicine, UK) downstream of the cytomegalovirus immediate
early promoter. Replication-de¢cient recombinant adenoviruses were
produced through homologous recombination, plaque puri¢ed, grown
to high titre and infectious titre, determined as described [3,23]. All
TIMP-3 plasmids and adenovirus inserts were fully sequenced on an
applied biosystems automated DNA sequencer to verify the mutations
and to ensure that no further mutations had been introduced.
Retinal tissue was obtained from eyes, donated with research per-
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mission to the Bristol CTS Eye Bank. The age of the donors was
under 40 yr and the RPE-choroid sheets were dissected from the
ocular globes within 36 h of death.
The human adenocarcinoma cell line, MCF-7, was obtained from
the American Tissue Culture Collection.
2.2. Tissue culture
Human RPE-choroid sheets dissected from ocular globes were frag-
mented using sterile forceps and a scalpel in a small quantity of MEM
supplemented with 10% v/v FCS, glutamine and the antibiotic mixture
in 5-cm-diameter Petri dishes. The fragmented tissue was then trans-
ferred into 25-cm3 culture £asks and left for a minimum period of 1 h
at 36‡C in a 5% CO2 incubator to allow the tissue to adhere to the
£asks. Additional MEM (2 ml) was then added to each £ask. After
7 days incubation under the same conditions, this was removed and
replaced with MEM containing 2.5% v/v FCS to prevent proliferation
of ¢broblasts. Subsequently this media was replenished every 3^4 days,
until the cell cultures became established. To propagate these cultures,
the cells were washed with Ca2þ-free PBS, trypsinised, collected by
centrifugation at 12 000 rpm for 3 min at room temperature, resus-
pended in fresh MEM medium containing 10% v/v FCS and reseeded
into multiple 75-cm3 culture £asks. For obtaining the cells used ex-
perimentally, this passaging procedure was never repeated more than
twice. The purity of the RPE cell cultures was checked by immuno-
staining for cytokeratins 4, 5, 6, 8, 10, 13 and 18 and pan-cytokeratin
18 using corneal keratocyte cultures as a control cell line [21].
MCF-7 cells were maintained at 37‡C in DMEM supplemented
with 10% FCS (v/v) and antibiotics. All established cell cultures
were maintained at 37‡C in an atmosphere of 95% air and 5% CO2.
2.3. Methods of transduction
Prior to transfection, trypsinised RPE and MCF-7 cells were plated
out, in triplicate, into six-well plates at densities of V2.5U105 cells/
well and incubated in DMEM media containing 10% v/v FCS until
the cells achieved around 80% con£uence (approximately 24 h). For
lipofection, the cells were washed twice with OptiMEM, and then
incubated with OptiMEM-containing plasmid DNA and Lipofectam-
ine1 (1 ml total volume). After 6 h an equal volume of DMEM
containing 20% v/v FCS was added. After a further 18 h, the medium
was replaced with 2 ml DMEM containing 10% v/v FCS and the
transfected cells were left for a further 48 h. Alternatively, cells
were incubated with adenovirus overnight and then the virus was
washed o¡ and the cells incubated in fresh medium for 48 h.
2.4. Quanti¢cation of the viable cells number and cell death
Triplicate cell cultures were trypsinised and mixed with an equal
volume of trypan blue dissolved in 0.9% saline (0.2% w/v) and the
cells that excluded the dye were counted with a haemocytometer.
Alternatively, propidium iodide (1 mg/ml stock solution, diluted
1:4000 for use) was added to each well. Permeable were counted
microscopically at U400 magni¢cation in three visual ¢elds. Total
cells numbers were subsequently counted after rendering all cells leaky
with formalin (10% v/v in PBS), and the percentage permeability was
calculated.
In situ end labelling (ISEL) technique was carried out on cells, were
plated out in triplicate on sterile glass coverslips. Cells were ¢xed in
10% v/v formalin for 10 min and washed twice in TE bu¡er, (10 mM
Tris^HCl, pH 8.0, 1 mM EDTA). The cells were incubated for 15 min
at 20‡C with DNA end labelling reagents (Boehringer kit containing
50 mM Tris^HCl, pH 7.2, 10 mM MgSO4, 0.1 mM dithiotreitol,
0.01 mM dATP, dCTP, dGTP, 0.01 mM biotinylated-dUTP) and
8 U/ml Klenow enzyme (Promega, UK). Cells were rinsed in TE
and endogenous peroxidase activity was inhibited by incubation
with 2% H2O2 for 5 min. After further washing, biotin was labelled
with Extravidin1 peroxidase in 10% FCS/PBS (1:200 dilution). Incu-
bation in diaminobenzidine was used to distinguish positive nicked
DNA from negative DNA.
2.5. Detection and quanti¢cation of wild-type TIMP-3 and SFD
TIMP-3 proteins
After transfection, the RPE and MCF-7 cells and their matrices
were harvested in PBS containing 2% w/v SDS (100 Wl/well). After
centrifugation the solubilised proteins in these samples were collected
and stored at 320‡C. Samples of these proteins were reduced with
mercaptoethanol (2%), boiled for 2 min and aliquots (20 Wl) were
diluted 20-fold with PBS and, using a dot blotter (Biorad), loaded
onto pre-wetted PDVF membranes in triplicate alongside serially di-
luted reference TIMP-3 samples. The membranes were blocked in
bu¡er containing 5% w/v milk powder and 5% v/v mercaptoethanol
incubated with the primary antibody raised against loop-1 of human
TIMP-3 (Chemicon) and HRP-conjugated secondary antibodies, and
the antibody/antigen complexes were visualised using Luminol (ECL
Kit, Amersham Pharmacia) as the HRP substrate. The intensities of
the dots that appeared on photographic ¢lm were determined using a
UVP gel documentation system and their image analysis software
(UVP, Cambridge, UK).
3. Results
We used plasmid constructs containing cDNA for wild-type
and four SFD TIMP-3 mutants (Ser-156, Gly-167, Tyr-168
and Ser-181) to compare human RPE cells with MCF-7 ad-
enocarcinoma cells, which are known to be susceptible to the
apoptotic e¡ects of wild-type TIMP-3 [3]. In preliminary ex-
periments, approximately 25% and 20%, respectively, of cul-
tured RPE and MCF-7 cells were transfected under the same
conditions with green £uorescent protein. Lipofectamine1 it-
self reduced viable cell numbers of RPE and MCF-7 cells to
73P 2% and 72P2% (n=4, P6 0.001), irrespective of the con-
centration of plasmid DNA added (1 or 2 Wg). All subsequent
transfections were carried out using Lipofectamine1 and a
total of 2 Wg plasmid DNA, while Lipofectamine1 alone
served as the experimental control.
Transient transfections of wild-type and Ser-156, Gly-167,
Tyr-168 and Ser-181 SFD mutant TIMP-3s all led to secretion
of discrete species of the expected sizes and no other bands by
Western blotting (results not shown). We therefore used the
simpler dot blotting technique for quanti¢cation. Similar
amounts of wild-type and Ser-156, Gly-167 or Ser-181 mutant
proteins were found in the respective cultures of RPE and
MCF-7 cells (Fig. 1, in all cases Ps 0.2). With the Tyr-168
mutant cDNA TIMP-3 levels were lower and not signi¢cantly
di¡erent than those in the respective untransfected, control
cultures of RPE and MCF-7 cells (Fig. 1, Ps 0.2).
Total viable RPE and MCF-7 cell numbers were signi¢-
cantly decreased by either wild-type or SFD mutant TIMP-3
(Fig. 2A, P6 0.001 in all cases). Overexpression of wild-type
TIMP-3 reduced the number of viable RPE and MCF-7 cells
by 50P 9% and 57P 6%, respectively (P=0.07). In addition,
as indicated in Fig. 2A, overexpression of the SFD mutant
TIMP-3 proteins killed signi¢cantly more RPE cells than the
wild-type TIMP-3. In the case of the MCF-7 cells, only the
Ser-181 and Gly-167 mutants caused signi¢cantly more cell
death than wild-type TIMP-3.
Fig. 1. Quantitative analysis TIMP-3 production. Data show the rel-
ative amounts of TIMP-3 produced by RPE and MCF-7cells trans-
fected with plasmid containing wild-type and the SFD mutant
TIMP-3 DNA inserts. *P6 0.001 compared with wild-type TIMP-3
production (n=3 separate experiments).
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Staining with propidium iodide exhibited the characteristic
features of apoptosis, including shrinkage and nuclear chro-
matin clumping (not shown). Wild-type TIMP-3 overexpres-
sion reduced RPE and MCF-7 viability measured with propi-
dium iodide by 49P 5% and 61P4% (n=9), respectively.
These values are statistically signi¢cant (P6 0.001) and sup-
port the possibility that MCF-7 cells are more susceptible to
the e¡ects of wild-type TIMP-3 than RPE cells. Each of the
Ser-156, Gly-167 and Ser-181 mutants was more e¡ective than
wild-type TIMP-3, statistical signi¢cance being reached in
both RPE and MCF-7 cells. Furthermore, given that Tyr-
168 mutant TIMP-3 expression was low compared to the
wild-type and other SFD TIMP-3 proteins, the pronounced
apoptotic e¡ect seen with this SFD mutant TIMP-3 is remark-
able.
In a subset of the cell cultures, ISEL was used as additional
or con¢rmatory evidence that the wild-type and SFD mutant
TIMP-3 proteins induce apoptosis of RPE and MCF-7 cells.
Fig. 3 shows the dark, condensed, ISEL-positive apoptotic
RPE and MCF-7 cell nuclei. From ISEL it was calculated
that wild-type TIMP-3 overexpression reduced RPE and
MCF-7 viability by 48P 3% and 62P 3% (Fig. 4, n=3), re-
spectively. These di¡erences are again statistically signi¢cant
(P= 6 0.001) and con¢rm that the MCF-7 cells are more
susceptible to the apoptotic e¡ects of wild-type TIMP-3
than RPE cells. The percentages of RPE and MCF-7 cells
undergoing apoptosis in response to excess wild-type and
SFD mutant TIMP-3 protein production (Fig. 4) were con-
sistent with values of cell viability presented in Fig. 2.
We previously showed that adenovirus-mediated overex-
Fig. 2. Cell viability in transfected cultures. A: Relative numbers of
RPE and MCF-7 cells that excluded trypan blue remaining 48 h
after transfection with wild-type or SFD mutant TIMP-3 compared
to cells treated with Lipofectamine alone. B: The proportion of cells
with nuclei stained with propidium iodide in the same cell cultures.
For comparison with panel A the values are expressed as viability,
i.e. 100-percentage stained. *P6 0.001, **P6 0.005, ***P6 0.006
compared with wild-type TIMP-3 (n=9).
Fig. 3. Detection of apoptotic cells with ISEL. Representative photographs (U83 magni¢cation) of cultured RPE and MCF-7 cells before
(a and c, respectively) and after (b and d, respectively) transfection with wild-type TIMP-3. An arrow in panels b and d shows a typical ISEL-
positive cell.
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pression of wild-type TIMP-3 also causes apoptosis in RPE
and cells MCF-7 [3,23]. To con¢rm the main ¢ndings with
plasmid-mediated overexpression, we prepared an adenovirus
that drove expression of the Gly-167 SFD mutant TIMP-3.
Increasing doses of virus expressing wild-type and the Gly-167
SFD mutant caused increasing levels of death of RPE and
MCF-7 cells. At each dose, however, slightly but signi¢cantly
more cells died with the Gly-167 SFD mutant (Fig. 5A,B).
4. Discussion
The ability of SFD mutant TIMP-3 to induce apoptosis has
not been investigated previously in any cell type. Among the
TIMP proteins, TIMP-3 is unique in that it has a high a⁄nity
for cellular matrices and, when expressed at high concentra-
tion, induces apoptosis in some but not all cell types
[2,3,24,25]. The apoptotic e¡ect of TIMP-3 is not shared by
TIMP-1 or TIMP-2 or by several broad spectrum synthetic
MMP inhibitors [3,5]. Nevertheless, it does require an intact
MMP inhibitory domain [5], and our demonstration here that
each of the SFD mutants also promoted apoptosis is consis-
tent with this ¢nding. The most likely mechanism for TIMP-3-
induced apoptosis is inhibition of a cell surface metalloprotei-
nase that normally releases a death ligand from the surface of
susceptible cells [2]. Consistent with this, recent observations
demonstrate that TIMP-3-induced apoptosis is inhibited by
dominant negative death-receptor domains and by inhibitors
of caspases linked to death receptors [26]. The nature of the
death ligand involved may, however, be di¡erent in di¡erent
cell types, and the nature of the target MMP is unclear [26].
To investigate the apoptotic of SFD mutant TIMP-3, we
used plasmid- and adenovirus-mediated transduction rather
than the simple addition of proteins because it has proved
extremely di⁄cult to prepare the recombinant forms of the
SFD mutants (unpublished results). However, previous stud-
ies with wild-type TIMP-3 demonstrate that similar results are
obtained using gene transfer and addition of proteins [3]. In
this study, plasmid-mediated TIMP-3 overexpression induced
apoptosis of greater than 50% of RPE or MCF-7 cells, even
though transfection e⁄ciency was 20^25%. These results con-
¢rm that there is a bystander e¡ect for TIMP-3-mediated ap-
optosis [3], and rule out that cells die as a result of internal
accumulation of the TIMP-3.
The data show that SFD mutations modestly increased the
apoptotic e¡ect of TIMP-3 on RPE cells. This was con¢rmed
by three di¡erent measures of cell death using plasmid-medi-
ated overexpression. Total cell counts include all methods of
cell death, propidium iodide staining gives morphological evi-
dence of apoptosis and in situ end labelling is also diagnostic
for apoptosis. Furthermore, adenovirus-mediated transduc-
tion gave a similar conclusion for the Gly-167 mutant at three
di¡erent doses. Given the limitations in quantifying TIMP-3
by dot blotting, the small di¡erences in the sensitivity of RPE
cells to wild-type and SFD TIMP-3 should not be overinter-
preted. The apoptotic e¡ect of the Tyr-168 mutant TIMP-3
may actually be considerably greater than that of the wild-
type protein, but con¢rmation of this will require the develop-
ment of a more sensitive assay for TIMP-3 levels. Neverthe-
less, we do not believe that, by itself, the small increase in
apoptotic e¡ect of SFD mutants is likely to fully account for
the SFD phenotype.
The dominant nature of the pattern of inheritance of SFD
suggests a gain of function mutation. Surprisingly, given the
widespread distribution of TIMP-3 throughout the body, oc-
ular disease is the only known consequence of the mutations.
The sequence of events leading from the production of a mu-
tant TIMP-3 protein to the formation of the characteristic
neovascular complex in the macular region of the eye is pres-
ently unknown [16]. Choroidal neovascularisation is common
to any condition that causes thickening of the Bruch’s mem-
brane, and histopathological studies have shown that exces-
sive TIMP-3 deposition occurs in both ARMD and SFD eyes
[16,21]. Mutant TIMP-3 accumulation could reduce the rate
of turnover of the Bruch’s membrane through MMP inhibi-
tion and the resultant pathological thickening could inhibit
the £ow of nutrients to RPE cells and cause their demise.
Fig. 4. Apoptosis quanti¢ed by in situ end labelling. The percentage
of RPE and MCF-7 cells positive for ISEL was counted 48 h after
transfection with wild-type or SFD mutant TIMP-3. For compari-
son with Fig. 2, the values are expressed as viability, i.e. 100-per-
centage stained. Statistical signi¢cance by Student’s t-test as:
*P6 0.001, **P6 0.005, ***P6 0.01 compared with wild-type
TIMP-3 (n= three separate experiments).
Fig. 5. Cell viability in adenovirus infected cultures. Relative num-
bers of RPE (A) and MCF-7 (B) cells that excluded trypan blue re-
maining 48 h after infection with increasing concentrations (plaque
forming units/ml) of adenoviruses that drive expression of wild-type
or Gly-167 SFD mutant TIMP-3 compared to control cells infected
with adenovirus driving L-galactosidase expression. *P6 0.05 com-
pared with wild-type TIMP-3 (n= three separate experiments).
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However, given our demonstration that wild-type and mutant
TIMP-3 overexpression caused apoptosis of RPE cells, we
suggest that RPE apoptosis triggered by accumulation of mu-
tant TIMP-3 could also be a contributory mechanism.
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